Aviation 3030 Pty Ltd (in liq) v Lao, in the matter of Aviation 3030 Pty Ltd (in liq) [2022] FCA 458
The March 2016 Share Issue was an unreasonable director-related transaction within s 588FDA because it significantly diluted existing shareholders’ value by issuing 76 million shares to a director’s related entity (Lao Holdings) for grossly less than market value without adequate disclosure; recovery is appropriate notwithstanding the company's solvency, and the proper remedy is to require Lao Holdings to pay $9,044,000 to the company, representing the difference between the option price paid and the median price paid by early investors, as this cures the essential inequity caused by the lack of disclosure and dilution, without conferring an unearned windfall on early investors or unduly...
- Parties
- First Plaintiff: Aviation 3030 Pty Ltd (in liquidation) (ACN 150 720 317); Second and Third Plaintiffs: George Georges and John Lindholm (liquidators); First Defendant: Hakly Lao; Third Defendant: Lao Holdings Pty Ltd (ACN 160 597 142); Seventh Defendant: Heng Kim Ou
- Jurisdiction
- Australia
- Judgment Date
- 29 April 2022
- Procedural Posture
- Corporations Act Liquidation/s 588 FDA Claim / First Instance Judgment on Liability and Remedy
- Outcome
- Principal claim allowed against the Third Defendant (Lao Holdings); eligibility for recovery established; dismissal as to Seventh Defendant; directions for final orders reserved.
- Legal Topics
- Unreasonable Director Related Transaction, Liquidation, Creditor Recovery, Share Dilution, Disclosure Obligations, Breach of Director’s Duties, Solvent Liquidation
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Aviation 3030 Pty Ltd (in liquidation) (ACN 150 720 317)
First Plaintiff
George Georges and John Lindholm (liquidators)
Second and Third Plaintiffs
Hakly Lao
First Defendant
Lao Holdings Pty Ltd (ACN 160 597 142)
Third Defendant
Heng Kim Ou
Seventh Defendant
Procedural Posture
Corporations Act Liquidation/s 588 FDA Claim / First Instance Judgment on Liability and Remedy
Legal Issues
- 1 Whether the March 2016 Share Issue was an unreasonable director-related transaction under s 588FDA of the Corporations Act 2001 (Cth)
- 2 Whether s 588FF(4) operates to allow recovery in a solvent liquidation for such a transaction
- 3 Whether appropriate disclosure was made to early shareholders regarding founder share options
Ratio Decidendi
The March 2016 Share Issue was an unreasonable director-related transaction within s 588FDA because it significantly diluted existing shareholders’ value by issuing 76 million shares to a director’s related entity (Lao Holdings) for grossly less than market value without adequate disclosure; recovery is appropriate notwithstanding the company's solvency, and the proper remedy is to require Lao Holdings to pay $9,044,000 to the company, representing the difference between the option price paid and the median price paid by early investors, as this cures the essential inequity caused by the lack of disclosure and dilution, without conferring an unearned windfall on early investors or unduly...
Court Disposition
Principal claim allowed against the Third Defendant (Lao Holdings); eligibility for recovery established; dismissal as to Seventh Defendant; directions for final orders reserved.
Orders
- Declaration that the March 2016 Share Issue is an unreasonable director-related transaction within s 588FDA of the Corporations Act 2001 (Cth).
- Pursuant to s 588FF(4), Lao Holdings Pty Ltd to pay Aviation 3030 Pty Ltd (in liquidation) $9,044,000 in respect of the shares issued to it; payment to be set off against Lao Holdings’ distribution on winding up.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment